- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 797
Nav nabs series C funding
Goldman Sachs has led the business financial management platform's $44.8m series C round, which included existing investors Experian and CreditEase's corporate venturing units.
Feb 12, 2019Siegel seeks out board position at Illumina
GE’s chief innovation officer and GE Ventures’ CEO, Sue Siegel, has been appointed by Illumina to sit on its board of directors.
Feb 12, 2019Hinge completes Match union
Match Group, which acquired a 51% stake in CAA-backed dating app Hinge last summer, has purchased the remaining shares in the business.
Feb 12, 2019NuVera veers toward $15m
The General Electric-backed medical device developer has reached a first close of a $15m round that was led by Cormorant and backed by Lilly Asia Ventures.
Feb 12, 2019UL takes a risk on KenSci in $22m round
UL Ventures' parent company will offer assistance in growth and compliance to the healthcare risk assessment platform developer, which has just raised series B funding.
Feb 12, 2019KenSci foretells $22m series B
The UW-founded healthcare forecasting software developer has collected $30.5m in all from backers including OUP and a unit of compliance firm UL.
Feb 12, 2019Arkansas opens Gap Fund
The fund has an annual budget of $400,000 and will complement two other schemes under the university Chancellor’s Fund for Innovation and Collaboration.
Feb 12, 2019IU commences dig at the Quarry
Indiana University has retooled its entrepreneurial support offering to enhance its services in business case development, executive recruitment and the sourcing of capital.
Feb 12, 2019SoftBank Vision Fund delivers $940m to Nuro
Nuro has already begun trialling its self-driving delivery vehicle and will use the funding to move into new cities and further develop the technology.
Feb 11, 2019Harpoon snags public markets listing
The Taiho and Eli Lilly-backed immunotherapy developer floated in the middle of its range to raise $75.6m, valuing it at about $334m.
Feb 11, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


